Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04665401
Other study ID # MERIT EAR Study
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2016
Est. completion date March 15, 2020

Study information

Verified date December 2020
Source Indiana University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Social functioning deficits are among the most disabling and difficult to treat aspects of schizophrenia. An essential component of social functioning is metacognition-a process that is profoundly disrupted in schizophrenia and represents the ability to reflect upon the mental states of oneself and others. To date, treatment efforts in schizophrenia have been hindered by barriers in accurately monitoring client's real-world social interactions. Recently, wearable technologies have evolved to provide therapists with innovative, ecologically-valid tools. The Electronically Activated Recorder is a wearable audio recorder that collects behavioral samples at pre-programmed intervals; it holds great promise as a method for yielding concrete, real-world examples of social interactions that can be used by therapists in session to enhance metacognition. Despite the immense costs of social functioning deficits, no previous studies have investigated whether functioning can be improved by integrating wearable audio recorders with psychosocial interventions. By enhancing therapy using a wearable recording device, this proposal's primary goal is to implement a novel intervention that targets metacognitive deficits to improve social functioning. The novel intervention will be tailored to individual clients-based on the content of recorded social interactions-in a way that is not possible using traditional psychotherapy. This will allow clients and therapists to step out of the therapy room by offering a window into how clients process material in real-world interactions. In this study, a randomized controlled trial will be conducted with two schizophrenia groups receiving six months of individualized: 1) Metacognition Reflection and Insight Therapy (MERIT) alone (Standard MERIT); and 2) Tailored MERIT using wearable audio recorders. In this study, our specific aims will test feasibility, effectiveness, and acceptability of Tailored MERIT.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date March 15, 2020
Est. primary completion date March 15, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Positive screen for metacognitive dysfunction - Serious Mental Illness diagnosis (schizophrenia-spectrum) - Age 18-60 - English fluency - Currently in non-acute phase of illness Exclusion Criteria: - Inability to provide informed consent - Current substance dependence - Documented intellectual disability

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Tailored MERIT
see arm description
Standard MERIT
see arm description

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Indiana University

Outcome

Type Measure Description Time frame Safety issue
Primary Global Functioning Scale: Social (GFS) 10-point measure of social functioning (1 to 10, with increasing scores indicating greater social functioning) Change from baseline social functioning to social functioning after 6 months of MERIT
Primary Metacognitive Beliefs Questionnaire-Brief (MCQ-30) 30 item measure of metacognition; each item is rated on a 1 to 4 scale with decreasing scores representing better metacognitive functioning. Change from baseline metacognition to metacognition after 6 months of MERIT
Primary The Positive and Negative Syndrome Scale (PANSS) 30 item measure of symptoms; each item is rated 1 to 7, with greater scores representing more severe symptoms (and lower scores indicating better functioning) Change from baseline symptoms to symptoms after 6 months of MERIT
Primary EAR Adherence Objective measure of how often EAR was worn; 0 (not worn) and 1 (worn) scores given at each of 48 potential time points. Total score represents frequency that the EAR is worn across all time points. Average of EAR adherence from baseline and 6 month assessment sessions
Primary EAR Experiential Questionnaire Assessment of how acceptable wearing the EAR was and how typical days were that EAR was worn. Scores for each item range from 1 to 5 with greater scores indicating greater problems (and lower acceptability). Average of EAR acceptability from baseline and 6 month assessment sessions
Secondary Quality of Life Scale 21 item measure of quality of life; each item is rated from 0 to 6, with greater scores indicating greater quality of life. Change from baseline quality of life to quality of life after 6 months of MERIT
Secondary Metacognition Assessment Scale- Abbreviated (MAS-A) Clinician-rated measure of metacognition using a semi structured clinical interview; four areas of capacity are rated (0 to 28 on overall scale); for each, increasing scores represent greater capacity. Change from baseline metacognitive capacity to metacognitive capacity after 6 months of MERIT
Secondary Short Form Health Survey (SF-36 36 item measure of social functioning and general health behaviors; each item on a different scale but greater scores indicate better overall functioning. Change from baseline functioning to functioning after 6 months of MERIT
Secondary Objective Behaviors from the Electronically Activated Recorder EAR coding can be implemented to rate different forms of objective behaviors; codes generated using different scales but primarily use a 0 (not present) or 1 (present) coding scheme. Greater scores typically represent presence of that which is being coded. Baseline, 3 months into MERIT, 6 months into MERIT (MERIT completed)
Secondary Scale to Assess Unawareness of Mental Disorder Insight measure; three items rated on 1 to 5 scale, with increasing scores indicating poorer insight. Baseline, 3 months into MERIT, 6 months into MERIT (MERIT completed)
See also
  Status Clinical Trial Phase
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Recruiting NCT04298450 - ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention N/A
Enrolling by invitation NCT03090490 - 10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals N/A
Completed NCT03323437 - Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia Phase 4
Completed NCT06040944 - Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
Recruiting NCT04452175 - Cigarette Consumption After switchinG to High or Low Nicotine strENght E-cigaretteS In Smokers With Schizophrenia N/A
Completed NCT03501888 - Cognitive Behavior Therapy for Patients With Psychoses. N/A
Completed NCT05601063 - Ascertaining Diagnosis Classification With Elicited Speech
Recruiting NCT05877716 - EPI-MINN: Targeting Cognition and Motivation - National N/A
Completed NCT03955549 - Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial Phase 3
Completed NCT03235908 - Copeptin in Outcome Prediction of an Acute Psychotic Episode
Recruiting NCT05622201 - A Randomized Controlled Trial With Rituximab for Psychotic Disorder in Adults Phase 2
Recruiting NCT05491486 - Mindfulness, Empathy and the Oxytocinergic System in Persons With Schizophrenia N/A
Recruiting NCT04916496 - Acceptance and Commitment Therapy-based Lifestyle Counselling Programme for Early Psychosis on Physical Activity N/A
Recruiting NCT04104347 - Metacognitive Training and Insight in Schizophrenia N/A
Recruiting NCT05664594 - State Representation in Early Psychosis - Project 4 N/A
Recruiting NCT05538832 - Remote State Representation in Early Psychosis Early Phase 1
Completed NCT02220504 - 3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals N/A
Recruiting NCT03919760 - Early Psychosis Intervention - Spreading Evidence-based Treatment
Completed NCT03449407 - Multi-dimensional Investigations of Negative Emotions and Drug-resistant Auditory Verbal Hallucinations in Psychosis